Cardiopulmonary complications of connective tissue diseases (CTDs), particularly pulmonary arterial hypertension (PAH) and interstitial lung disease (ILD), are major determinants of morbidity and mortality. Multidisciplinary meetings may improve diagnostic accuracy and optimise treatment. We review the literature regarding multidisciplinary meetings in CTD‐ILD and PAH and describe our tertiary centre experience of the role of the multidisciplinary meeting in managing CTD‐PAH. [ABSTRACT FROM AUTHOR]